Postmenopausal osteoporosis Trials in Warsaw, Poland
Conditions / Postmenopausal osteoporosis / Warsaw, Poland
Clinical trials for Postmenopausal osteoporosis investigate a range of treatment strategies and patient populations.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01575834 | Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis | COMPLETED | PHASE3 |
| NCT01796301 | An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women | COMPLETED | PHASE3 |
| NCT05405725 | A Phase 3 Study to Compare Biosimilar Denosumab With Prolia® | COMPLETED | PHASE3 |
| NCT00247273 | A Study of Monthly Risedronate for Osteoporosis | COMPLETED | PHASE3 |
| NCT06577935 | A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT00541658 | A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis | COMPLETED | PHASE3 |
| NCT01709110 | VERtebral Fracture Treatment Comparisons in Osteoporotic Women | COMPLETED | PHASE4 |
| NCT05087030 | Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis | COMPLETED | PHASE3 |
| NCT04064411 | Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis | COMPLETED | PHASE3 |
| NCT01343004 | Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women | COMPLETED | PHASE3 |